Pancreatic cancer survival has finally doubled in a decade to 13 percent, a fragile but real sign that years of slow, methodical progress are beginning to add up. November is Pancreatic Cancer ...

Researchers advance mRNA cancer therapies as France tests new methods, while the FDA approves Bayer’s Hyrnuo for HER2-mutated ...

Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer Society. It typically causes no symptoms until it has already metastasized ...

Medical researchers are celebrating after a vaccine is showing promising results in response to pancreatic cancer. Although it’s still in the early trial stage, this one-size-fits-all treatment could ...

The vaccine could be a game changer for Black people, who are disproportionately impacted by both cancers. According to the American Cancer Society, Black men and women have higher incidence rates and ...

A new pancreatic cancer therapy targets sugar molecules on cell surfaces, offering hope where traditional immunotherapies have failed in treating this deadly disease.

Advances in targeted therapies, especially those targeting KRAS mutations, and cancer vaccines show promise in pancreatic ...

Research shows that gastrointestinal cancers — including stomach, liver, esophageal, pancreatic, and colorectal cancers — account for about 26% of all cancers worldwide and 35% of all cancer-related ...

Pancreatic cancer is hard to find early, which is why we are bringing attention to it on this World Pancreatic Cancer ...

Learn the subtle early signs of pancreatic dysfunction and cancer. Discover how early detection and advanced imaging can ...